Literature DB >> 844888

The effect of immunological adjuvants on the relative affinity of anti-protein antibodies.

R E Petty, M W Steward.   

Abstract

Inbred mice of a strain (B1OD2 new) known to produce either no detectable antibody or antibody of low affinity to two protein antigens administered in saline, were immunized with human serum transferrin (HST) in one of nine adjuvants. Such immunization increases the level and relative affinity of anti-HST antibody. The adjuvants used varied in the degree to which they augmented these parameters of the antibody response--that is, FCA and FIA were capable of inducing high levels of high affinity antibody, whereas other adjuvants elicited lower levels of high affinity antibody. The possibility is discussed that substances with adjuvant activity may effect antibody production at two stages: (1) at the stage of antigen selection of cells for proliferation and (2) at the stage or proliferation of antibody producing cell precursors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844888      PMCID: PMC1445198     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin.

Authors:  E S Golub; W O Weigle
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

2.  The relationship between antibody affinity and the efficiency of complement fixation.

Authors:  A S Fauci; M M Frank; J S Johnson
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

3.  The mode of action of mineral-oil emulsion adjuvants on antibody production in mice.

Authors:  W J Herbert
Journal:  Immunology       Date:  1968-03       Impact factor: 7.397

4.  Adjuvanticity of vitamin A.

Authors:  D W Dresser
Journal:  Nature       Date:  1968-02-10       Impact factor: 49.962

Review 5.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

6.  The immunopathological significance of the heterogeneity of antibody affinity.

Authors:  J F Soothill; M W Steward
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

7.  Antigenicity of soluble protein in the presence of high levels of antibody: a possible mode of action of the antigen adjuvants.

Authors:  W J Herbert
Journal:  Nature       Date:  1966-05-14       Impact factor: 49.962

8.  Studies on antibody affinity at the cellular level. Correlation between binding properties of secreted antibody and cellular receptor for antigen on immunological memory cells.

Authors:  B Andersson
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

9.  Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized.

Authors:  G W Siskind; P Dunn; J G Walker
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

10.  Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  5 in total

1.  DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

Authors:  J S Boyle; A Silva; J L Brady; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

2.  Interferon-gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation.

Authors:  G P Holland; N Holland; M W Steward
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 3.  Neutralization of animal viruses.

Authors:  B Mandel
Journal:  Adv Virus Res       Date:  1978       Impact factor: 9.937

4.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

5.  Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity.

Authors:  Lokesh Agrawal; W Haq; Carl Veith Hanson; D Nageswara Rao
Journal:  J Immune Based Ther Vaccines       Date:  2003-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.